The community pharmacy standard supports information sharing between community pharmacists and GP practices.
Pharmacies are offering an increased range of services to support care for people in the community. It is essential that they are able to share vital information about a person's care with GP practices and other services. By doing this digitally, we can ensure that care professionals have timely access to relevant information, leading to better, safer and more personalised care.
The standard includes:
1. Vaccine administration
2. Emergency supply of medicine
3. New medicine service
4. Medication reviews (this includes the Medicine Use Review [MUR] as a contracted community pharmacy service in England, but also other types of medication review conducted by pharmacists in other settings, e.g. within care homes)
5. Appliance use reviews
6. Community Pharmacist Consultation Service (CPCS)
7. Discharge from hospital to pharmacy services.
What are the benefits?
- Timely sharing of clinically relevant data in relation to pharmacy services undertaken to other NHS providers.
- Transfer of standardised coded data sets to patients’ primary care health record.
- A more comprehensive patient health record with the inclusion of clinically relevant outcomes from pharmacy services, which has the potential to improve medication safety and support medicines optimisation.
- Reduced administrative burden due to elimination of paper templates and transfer of information through non-direct routes into patients’ primary care health record.
- Improved communication methods support community pharmacy to take on a greater range of clinical services to reduce burden on other parts of the health and care system, and also ensures that the clinical contribution of community pharmacists is visible to the wider NHS.
The standard has been produced in collaboration with NHS Digital and the Royal College of Physicians. Clinical leadership for the project was provided by the Royal Pharmaceutical Society and the Royal College of General Practitioners, as well as other professionals, to ensure the right information is recorded.
The standard has been endorsed by the following key stakeholders.
- Royal College of General Practitioners
- Royal Pharmaceutical Society
- Pharmaceutical Services Negotiating Committee
- United Kingdom Clinical Pharmacy Association
A statement of support was provided from the following stakeholders:
- National Pharmacy Association
- Company Chemist Association
- Association of Independent Multiples Pharmacies
- British Healthcare Trades Association (endorsed standards 3-7 above as relevant to the organisation)
- Primary Care Pharmacy Association
- Implementation guidance v1.1
- Information model v1.1 (xls)
- FHIR profiles and specifications (stage 1)
- Release notes
- Release notes v1.1 - Jan 2021
- Release notes v1.0
* New revision: This standard has been revised and now brings together all the elements as a single community pharmacy standard. The aim is to encourage the pharmacy system suppliers to implement the standard as a whole rather than by individual use cases and streamlines the development of future functionality.
The standard has also been aligned with the core information standard and medications and now includes machine readable dose syntax. This will ensure consistency across standards as well as bringing it up to date with the latest developments.
Further updates in progress. Release planned Feb-21
GPs to receive more electronic flu vaccination notifications
NHS Digital has expanded its electronic flu notifications service, which is based on our pharmacy information standard and ensures that information about flu vaccinations can be shared digitally by pharmacies with GP practices. Read full story